Introduction
============

Approximately half of the world\'s population is infected with *Helicobacter pylori*(*H. pylori*). Atrophic change and intestinal metaplasia often occur during long-term *H. pylori* infection, which can lead to gastric adenocarcinomas [@JR528-1] [@JR528-2] [@JR528-3].

In Japan, national health insurance coverage for *H. pylori*eradication therapy to treat *H. pylori*-associated gastritis finally became available in February 2013. However, in order for a patient to qualify for health insurance coverage, endoscopy must first be performed to diagnose *H. pylori*-associated gastritis [@JR528-4].

Therefore, endoscopic examination is essential to make a diagnosis of *H. pylori*-associated gastritis. However, conventional white light imaging (WLI) endoscopy frequently correlates poorly with histopathological findings of *H. pylori*-induced gastritis [@JR528-5] [@JR528-6] [@JR528-7]. Recently, a focus has been placed on analyzing endoscopic images of the diffuse redness of the fundic mucosa in *H. pylori*-positive patients to diagnose infection. Using WLI, features of diffuse redness in the corpus and mucosal swelling in the antrum were shown to be hallmarks of *H. pylori* infection [@JR528-8]. Diffuse redness of the fundic mucosa was found significantly more frequently and covered more tissue area in *H. pylori*-positive patients (failed eradication) than in *H. pylori*-negative (successful eradication) patients in a multicenter prospective trial [@JR528-9]. However, this study did not sufficiently evaluate the ability of non-expert endoscopists to diagnose *H. pylori* by evaluating these images.

We evaluated linked color imaging (LCI), a color enhancement feature available for LASEREO systems (FUJIFILM Co., Tokyo, Japan) that makes slight differences in mucosal color easy to recognize. We predicted that differences between mucosal color tones would become easy to recognize with LCI, thus supporting a diagnosis of diffuse redness of the fundic mucosa, which is difficult to detect using WLI. We then investigated the ability of both expert and non-expert endoscopists to diagnose *H. pylori* infections using LCI and WLI.

Patients and methods
====================

Patients
--------

This was a single-center retrospective study conducted in the Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine. The study was approved by the University Ethical Review Committee and performed out in accordance with the Helsinki Declaration of the World Medical Association. In addition, this study was registered in the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) as number UMIN0000021674. All patients provided written informed consents to undergo esophagogastroduodenoscopy (EGD) using both WLI and LCI at the University Hospital, Kyoto Prefectural University of Medicine.

Consecutive patients who underwent EGD and following examinations to determine their *H. pylori*infection status between October 2013 and October 2014 at the University Hospital, Kyoto Prefectural University of Medicine, were selected for this study. We evaluated both patients with *H. pylori* infection and those who tested negative for*H. pylori* infection after eradication therapy in order to evaluate and compare whether LCI and WLI could detect diffuse redness and diagnose H. pylori infection accurately. The presence of *H. pylori*infection was determined by histologic examination, the rapid urease test (PyloriTek^®^; Serim Research Corp., Elkhart, IN, USA), serum antibody test, or ^13^C-urea breath test (UBit^®^; Otsuka, Tokyo, Japan). The absence of *H. pylori*infection was determined by the^13^C-urea breath test and histological examination at least 2 months after *H. pylori*eradication therapy. The following patients were excluded from this study: (1) patients without *H. pylori*infection and without atrophic mucosa; (2) patients with histories of *H. pylori*eradication within the previous 1 year; (3) patients with histories of gastric surgery; and (4) patients with severe liver, renal, cardiopulmonary dysfunction, or blood disease including severe anemia.

Endoscopic imaging
------------------

All examinations were carried out with a high-definition EG-L590WR endoscope corresponding to the LASEREO endoscopic system (FUJIFILM Co., Tokyo, Japan). In brief, this LASEREO system uses a semiconductor laser as the light source and has narrow-band light observation functions, BLI and LCI, without a customized optical filter. It uses 2 types of lasers, with 410-nm and 450-nm wavelengths. Both bandwidths are \< 2 nm, in contrast to the bandwidth for NBI (30 nm) [@JR528-10]. The laser with a 450-nm wavelength produces irradiated phosphor with an illumination similar to that produced by a xenon lamp. The combination of strong laser light with a wavelength of 450-nm and fluorescent light provides illumination that is almost equivalent to that of WLI. LCI is a new image-enhanced technology that is intended to enhance slight color differences in the red region in the mucosa. This mode is based on the image captured under similar light conditions in BLI-bright; however, further post-image processing is later applied so that the slightly reddish color becomes much redder and slightly whitish color becomes much whiter than the colors appear under WLI ([Fig. 1](#FI528-1){ref-type="fig"}). Ultimately, LCI improves the ability of the observer to recognize slight differences in mucosal color such as from inflammation or atrophy, compared to that with conventional WLI. WLI and LCI images were selected from the antegrade and retroflex views of the gastric body.

![ Linked color imaging (LCI) principle. After reallocating the acquired color information on a mucosal surface or blood vessel by simultaneously irradiating narrow-band short wavelength light and white light, LCI both expands and reduces color information so that a reddish color becomes redder and a whitish color becomes whiter. R. red; G, green; B, blue. **a** White light imaging. **b** LCI.](10-1055-s-0042-109049-i528ei1){#FI528-1}

In the case of *H. pylori* infectious gastritis, WLI shows a slight reddish mucosa in the entire fundic gland ([Fig. 2 a](#FI528-2){ref-type="fig"} and [Fig. 2 b](#FI528-2){ref-type="fig"}), while LCI shows a deep reddish (crimson) mucosa in the entire fundic gland ([Fig. 3 a](#FI528-3){ref-type="fig"} and [Fig. 3 b](#FI528-3){ref-type="fig"}). In the cases of *H. pylori-*negative stomach after eradication therapy, WLI shows an orange/yellow mucosa in the entire fundic gland ([Fig. 4 a](#FI528-4){ref-type="fig"} and [Fig. 4 b](#FI528-4){ref-type="fig"}), while LCI shows a light orange (white apricot) mucosa in the entire fundic gland ([Fig. 5 a](#FI528-5){ref-type="fig"} and [Fig. 5 b](#FI528-5){ref-type="fig"}).

![ Representative images of a case of *H. pylori* infectious gastritis. **a** White light imaging (WLI); gastric body from the retroflex view. **b** WLI; gastric body from the antegrade view.](10-1055-s-0042-109049-i528ei2){#FI528-2}

![ Representative images of a case of *H. pylori* infectious gastritis. **a** Linked color imaging (LCI); gastric body from the retroflex view. **b** LCI; gastric body from the antegrade view.](10-1055-s-0042-109049-i528ei3){#FI528-3}

![ Representative images of a case testing negative for*H. pylori* infection after eradication therapy. **a** White light imaging (WLI); gastric body from the retroflex view. **b** WLI; gastric body from the antegrade view.](10-1055-s-0042-109049-i528ei4){#FI528-4}

![ Representative images of a case testing negative for*H. pylori* infection after eradication therapy. **a** Linked color imaging (LCI); gastric body from the retroflex view. **b** LCI; gastric body from the antegrade view.](10-1055-s-0042-109049-i528ei5){#FI528-5}

Participating endoscopists
--------------------------

Four endoscopists who were blinded to the clinical data evaluated all endoscopic images. None of them performed the EGDs in this study. Two expert endoscopists (expert A and B) had previously performed over 10,000 conventional EGDs, while the other 2 were non-expert endoscopists (non-expert C and D) who had previously performed less than 2000 conventional EGDs.

Diagnostic evaluation
---------------------

Four endoscopists evaluated the images of the gastric fundic areas from the antegrade and retroflex views using each endoscopic modality (WLI and LCI). Images obtained with each modality were prepared for evaluation by placing them on a slide and displaying them independently of the images obtained with the other endoscopic modality ([Fig. 2](#FI528-2){ref-type="fig"} and [Fig. 3](#FI528-3){ref-type="fig"}). The criterion for diagnosing *H. pylori* infection using both WLI and LCI was the presence of diffuse redness of the fundic mucosa. Using WLI, the diagnostic criterion of *H. pylori* infection is a marked or slight redness involving the entire mucosa of the fundic gland, while using LCI, the diagnostic criterion is a deep red (crimson) color also involving the entire mucosa of the fundic gland.

In an independent experiment, we examined the interobserver and intraobserver variabilities of the endoscopists diagnosing *H. pylori* infection. All 4 endoscopists diagnosed the images from each case in the order of presentation in 1 day. One month later, the same images were presented in a different order for diagnosis by the same endoscopists.

Calculation of sample size
--------------------------

We evaluated the diagnostic differences in determining for *H. pylori* infection between WLI and LCI by the McNemar test in a pilot study of 24 patients. LCI was superior to WLI for diagnosing *H. pylori* infection in 8 patients (33 %), and the McNemar's odds ratio of LCI for WLI was 4.0. Thus, we needed 20 participants in order to detect the significant differences in diagnostic results with a probability (Power) of 0.8 and α error of 0.05. Because the proportion of patients with a different diagnosis in the response of matched pairs was 33 %, the required sample size was set to 60 patients (= 20/0.33).

Statistical analysis
--------------------

Continuous variables, such as patient age, were analyzed with the Mann-Whitney *U* test. Comparisons of incidences between 2 groups such as sex and atrophic border, were analyzed with Pearson's chi-squared test or Fisher's exact test. McNemar's test was used to compare diagnostic accuracy, sensitivity, and specificity between WLI and LCI. The diagnostic accuracy of each method is presented as a percentage. The Wilson score method was used to measure the 95 % confidence interval. Interobserver variability was quantified using the kappa statistic, which measures agreement over and above chance agreement. Kappa values of \< 0.20, 0.21 -- 0.40, 0.41 -- 0.60, 0.61 -- 0.80 and \> 0.80 are considered to indicate poor, fair, moderate, good and excellent agreement, respectively. *P* \< 0.05 was considered statistically significant. All statistical analyses were performed using SPSS software, Version 22.0 for Windows (IBM Japan, Ltd, Tokyo, Japan).

Results
=======

A total of 60 patients were evaluated in this study between October 2013 and October 2014. There were 30 patients with *H. pylori* infection and 30 patients who tested negative for*H. pylori* infection after eradication therapy. The clinical features of the patients are summarized in [Table 1](#TB528-1){ref-type="table"}.

###### Clinical features of patients.

                                                      *H. pylori*-positiven = 30   *H. pylori*-negativen = 30   ***P***
  --------------------------------------------------- ---------------------------- ---------------------------- ---------
  Gender                                                                                                        
   Male                                               19                           18                           n. s.
   Female                                             11                           12                           
  Median age                                          69.0                         65.5                         n. s.
  Atrophic border[1](#FN528-1){ref-type="table-fn"}                                                             
   C-1, C-2, C-3                                       5                            9                           n. s.
   O-1, O-2                                           22                           17                           
   O-3                                                 3                            4                           

Kimura-Takemoto classification system.

The mean accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for LCI diagnoses for the 4 endoscopists were 85.8 %, 93.3 %, 78.3 %, 81.2 %, and 92.2 %, respectively. On the other hand, the mean accuracy, sensitivity, specificity, PPV, and NPV for WLI diagnoses among the mean of 4 endoscopists were 74.2 %, 81.7 %, 66.7 %, 70.6 %, and 75.5 %, respectively. The accuracy and sensitivity for LCI were significantly higher than those for WLI (*P* = 0.002 and *P* = 0.011, respectively). The performance data from the 4 endoscopists are shown in [Table 2](#TB528-2){ref-type="table"}. The accuracy, sensitivity, specificity, NPV and PPV for LCI were higher for both experts and non-experts compared with WLI.

###### Diagnostic accuracy and predictive value of WLI and LCI among 4 endoscopists.

  **Endoscopist**   Accuracy              Sensitivity           Specificity           NPV                   PPV                                                                                                           
  ----------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- --------------------- ---------------------
  A                 76.7 (64.0 -- 86.6)   91.7 (81.6 -- 97.2)   63.3 (43.9 -- 80.0)   93.3 (77.9 -- 99.2)   90.0 (73.5 -- 97.9)   90.0 (73.5 -- 97.9)   64.3 (48.0 -- 78.4)   93.1 (77.2 -- 99.2)   85.0 (62.1 -- 96.8)   90.3 (74.2 -- 98.0)
  B                 83.3 (71.5 -- 91.7)   86.7 (75.4 -- 94.1)   90.0 (73.5 -- 97.9)   90.0 (73.5 -- 97.9)   76.7 (57.6 -- 90.1)   83.3 (65.3 -- 94.4)   88.5 (69.8 -- 97.6)   89.3 (71.8 -- 97.7)   79.4 (62.1 -- 91.3)   84.4 (67.2 -- 94.7)
  C                 63.3 (49.9 -- 75.4)   80.0 (67.7 -- 89.2)   80.0 (61.4 -- 92.3)   93.3 (77.9 -- 99.2)   46.7 (28.3 -- 65.7)   66.7 (47.2 -- 82.7)   70.0 (45.7 -- 88.1)   90.9 (70.8 -- 98.9)   60.0 (43.3 -- 75.1)   73.7 (56.9 -- 86.6)
  D                 73.3 (60.3 -- 83.9)   85.0 (73.4 -- 92.9)   93.3 (77.9 -- 99.2)   96.7 (82.7 -- 99.9)   53.3 (34.3 -- 71.7)   73.3 (54.1 -- 87.7)   88.9 (65.3 -- 98.6)   95.7 (78.1 -- 99.9)   66.7 (50.6 -- 85.3)   78.4 (61.8 -- 90.2)

CI, confidence interval; NPV, negative predictive value; PPV positive predictive value. WLI, white light imaging; LCI, linked color imaging.

The kappa values of interobserver variability between the four endoscopists for WLI were fair to moderate. The kappa values of interobserver variability between the 4 endoscopists for LCI were as follows: expert to expert was excellent; the others were moderate to good ([Table 3](#TB528-3){ref-type="table"}). The kappa values of intraobserver variability for WLI were as follows: A and D were good, B was fair, and C was moderate. The kappa values of intraobserver variability for LCI were as follows: A and B were excellent, and the others were good ([Table 4](#TB528-4){ref-type="table"}). The kappa values of interobserver and intraobserver variability for LCI were higher than those for WLI between all of the 4 endoscopists. In 7 cases with severe atrophic mucosa (O-3), there were 3 *H. pylori*-positive patients. All 3 patients were diagnosed as *H. pylori*-negative through the use of LCI by all 4 endoscopists.

###### Interobserver variability between expert and non-expert endoscopists.

  Endoscopist            A to B   A to C   A to D   B to C   B to D   C to D
  ---------------------- -------- -------- -------- -------- -------- --------
  Kappa values for WLI   0.24     0.39     0.37     0.37     0.49     0.28
  Kappa values for LCI   0.85     0.45     0.75     0.45     0.75     0.45

WLI, white light imaging; LCI, linked color imaging.

###### Intraobserver variability among 4r endoscopists.

  Endoscopist            A      B      C      D
  ---------------------- ------ ------ ------ ------
  Kappa values for WLI   0.73   0.39   0.47   0.64
  Kappa values for LCI   0.82   0.83   0.74   0.79

WLI, white light imaging; LCI, linked color imaging.

Discussion
==========

To our knowledge, this is the first report to compare the usefulness of LCI for diagnosing *H. pylori* infection to that of WLI. Endoscopic diagnosis of *H. pylori* infection in gastric mucosa has been established. A regular arrangement of collecting venules is an endoscopic feature with high sensitivity and high specificity for detecting *H. pylori*-negative normal stomachs [@JR528-11] [@JR528-12] [@JR528-13]. Studies using magnifying endoscopy or confocal laser endomicroscopy have shown endoscopic features associated with histopathologic findings related to *H. pylori* infection [@JR528-14] [@JR528-15]. However, it was very difficult to observe and diagnose*H. pylori* infection using these methods, and assessment of endoscopic findings depended on the skill level of the endoscopists.

Endoscopic findings, such as diffuse or spotty redness, mucosal swelling, and swelling of the gastric area, can be used as diagnostic indices for *H. pylori* infection [@JR528-8]. Diffuse redness in the fundic gland mucosa on histology was considered to reflect mucosal hyperemia due to inflammatory changes [@JR528-16]. A strong correlation with an objective index of redness, the hemoglobin index (IHb), has been reported, suggesting that diffuse redness is the most important feature for diagnosing *H. pylori* infection [@JR528-17]. Therefore, we hypothesized that LCI would detect diffuse redness more easily than would WLI.

The aim of our study was to evaluate whether LCI could detect this diffuse redness and diagnose *H. pylori* infection more accurately than could WLI. We excluded patients who did not have *H. pylori*infection, or atrophic mucosa, because the diagnostic accuracy of *H. pylori* infection by WLI is so high in these patients [@JR528-8]. Therefore, we evaluated *H. pylori* infection status between *H. pylori*-positive patients and *H. pylori*-negative patients with atrophic mucosa after eradication.

The diagnostic accuracy of both experts and non-experts using LCI was superior to those for WLI. However, the kappa values for interobserver variability of LCI for comparisons between experts and non-experts or non-experts and non-experts was \< 0.50, which showed only moderate agreement. This was due to the use of recorded images and lack of experience of all endoscopists with LCI. Therefore, all endoscopists should practice LCI in real time. Biopsy-based methods for diagnosing *H. pylori* infection, such as the rapid urease test, histology, and bacterial culture, have a low sensitivity [@JR528-18]. The accuracy of biopsy-based diagnosis using the Updated Sydney System [@JR528-19] was dependent on the local mucosal conditions of the biopsy sites. If the biopsy specimens are taken at sites of atrophic mucosa and intestinal metaplasia, biopsy-based diagnosis may show false-negative results. LCI can evaluate the whole fundic gland area compared with biopsy-based methods. However, there were 3 false-negative cases of LCI diagnosis by all 4 endoscopists. In those cases, LCI showed no diffuse redness due to severe atrophic change of gastric corpus. Those are limitations of LCI diagnosis.

Our study has limitations. First, the number of patients was small and the data are from a single center. Second, this study is a limited evaluation of recorded images in selected patients. Third, the relationship between LCI and the Updated Sydney System was not assessed in this study. Therefore, WLI and LCI examination combined with the Updated Sydney System will be needed for further multi-institutional studies with a large number of cases.

In conclusion, LCI can identify active *H. pylori* infection by emphasizing the diffuse redness of fundic gland mucosa. These results suggest that LCI improves endoscopic diagnostic accuracy of *H. pylori* infection compared with WLI.
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